Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,917
Total Claims
$832K
Drug Cost
756
Beneficiaries
$1,100
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-77%
Opioid rate vs peers
0.5% vs 2.2% avg
-22%
Cost per patient vs peers
$1,100 vs $1,411 avg
+6%
Brand preference vs peers
11.3% vs 10.6% avg
Opioid Prescribing
0.5%
Opioid Rate
45
Opioid Claims
$1,173
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 990 claims · $657K
Generic: 7,809 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 175 | $199K |
| Empagliflozin | 57 | $57K |
| Rivaroxaban | 38 | $56K |
| Insulin Glargine,hum.Rec.Anlog | 65 | $47K |
| Fluticasone Propion/Salmeterol | 55 | $33K |
| Semaglutide | 22 | $31K |
| Fluticasone/Vilanterol | 47 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $11K |
| Levothyroxine Sodium | 393 | $7,920 |
| Atorvastatin Calcium | 476 | $7,307 |
| Evolocumab | 11 | $6,282 |
| Umeclidinium Bromide | 14 | $5,981 |
| Gabapentin | 159 | $5,813 |
| Levothyroxine Sodium | 66 | $5,675 |
| Duloxetine Hcl | 130 | $5,234 |
Prescribing Profile
Patient Profile
75
Avg Age
47%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data